| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
56,893 | 40,757 | 24,008 | 46,663 | 54,035 |
|
Cost of Revenue
|
-26,155 | -23,801 | -13,819 | -24,901 | -26,759 |
|
Gross Profit
|
30,738 | 16,956 | 10,189 | 21,762 | 27,276 |
|
Selling, General and Administrative Expenses
|
-24,729 | -25,660 | -27,261 | -24,621 | -22,635 |
|
Research and Development Expenses
|
-7,804 | -8,106 | -9,644 | -8,127 | -7,010 |
|
Operating Income/Expenses
|
-32,533 | -33,766 | -36,905 | -32,748 | -29,645 |
|
Total Operating Profit/Loss
|
-1,795 | -16,810 | -26,716 | -10,986 | -2,369 |
| Total Net Finance Income/Expense
|
-1,407 | -1,290 | -366 | -- | -- |
| Net Investment Income
|
-2,681 | 730 | -3,950 | -- | -- |
| Irregular Income/Expenses
|
-- | -- | -- | 0 | -13,162 |
|
Other Income/Expense, Non-Operating
|
73 | -623 | -1,103 | -10 | 60 |
|
Non-Operating Income/Expenses, Total
|
-4,015 | -1,183 | -5,419 | -10 | -13,102 |
|
Pretax Income
|
-5,810 | -17,993 | -32,135 | -10,996 | -15,471 |
|
Provision for Income Tax
|
-369 | -119 | 405 | -7,400 | -741 |
|
Net Income from Continuing Operations
|
-6,179 | -18,112 | -31,730 | -18,396 | -16,212 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-6,179 | -18,112 | -31,730 | -18,396 | -16,212 |
|
Net Income after Non-Controlling/Minority Interests
|
-6,179 | -18,112 | -31,730 | -18,396 | -16,212 |
|
Net Income Available to Common Stockholders
|
-6,179 | -18,112 | -31,730 | -18,396 | -16,212 |
|
Diluted Net Income Available to Common Stockholders
|
-6,179 | -18,112 | -31,730 | -18,396 | -16,212 |
| Basic EPS
|
-0.14 | -0.40 | -0.72 | -0.50 | -0.44 |
| Diluted EPS
|
-0.14 | -0.40 | -0.72 | -0.50 | -0.44 |
|
Basic Weighted Average Shares Outstanding
|
45,287.5090 | 45,056.4360 | 44,316.8650 | 36,939.3350 | 36,495.0120 |
|
Diluted Weighted Average Shares Outstanding
|
45,287.5090 | 45,056.4360 | 44,316.8650 | 36,939.3350 | 36,495.0120 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-4,403 | -16,703 | -31,769 | -10,996 | -15,471 |
|
EBITDA
|
-882 | -13,157 | -28,046 | -7,666 | -12,914 |
|
Normalized EBITDA
|
2,543 | -12,368 | -22,135 | -6,786 | 2,414 |
|
Normalized Income
|
-2,495.2300 | -18,866.4500 | -26,188.7280 | -16,862.6100 | -1,027.6000 |
|
Total Unusual Items
|
4,663 | -955 | 5,612 | 1,941 | 15,722 |
|
Total Unusual Items Excluding Goodwill
|
4,663 | -955 | 5,612 | 1,941 | 2,560 |
9/30/2022 - 4/4/1994
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade